Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 2;8(9):e2530946.
doi: 10.1001/jamanetworkopen.2025.30946.

Patient and Physician Perceptions of Prostate-Specific Antigen Testing Among Black Individuals

Jenney R Lee  1 , Dante' Morehead  1 , Ben Young  2 , Victor Tolbert  2 , John Masembe  2 , Garrett Britt  3 , Lars Neuenschwander  3 , Kyle Schuppe  3 , Richard Pelman  4 , Debi Johnson  4 , Vida Henderson  5 , Burcu F Darst  5 , Patricia Egwuatu  6 , Sung Min Kim  1 , Erika M Wolff  1 , John L Gore  1 , Yaw A Nyame  1   5
Affiliations

Patient and Physician Perceptions of Prostate-Specific Antigen Testing Among Black Individuals

Jenney R Lee et al. JAMA Netw Open. .

Abstract

Importance: Black individuals have a twofold higher rate of prostate cancer death in the US compared with the average population with prostate cancer. Few guidelines support race-conscious screening practices among at-risk Black individuals.

Objective: To examine structural factors that facilitate or impede access to prostate cancer screening among Black individuals in the US.

Design, setting, and participants: This qualitative, mixed-methods study was conducted between September 1, 2021, and December 31, 2023, in clinical and community settings across Washington, Wyoming, Alaska, Montana, Idaho, and Oregon. It included semistructured interviews with Black adults (aged ≥18 years) at risk for prostate cancer with or without a history of prostate-specific antigen (PSA) testing and a survey of primary care practitioners (PCPs) and urologists.

Main outcomes and measures: Patient and physician experiences, knowledge, attitudes, and practices of PSA testing and prostate cancer screening were evaluated. Consensus coding and thematic analysis were used to analyze interviews; surveys were analyzed using descriptive statistics.

Results: A total of 29 Black men (median [range] age, 59 [32-72] years) participated in the interviews, and 31 PCPs (including 30 phyicians and 1 physician assistant) and 32 urologists (45 of 63 aged 30-59 years [71.4%]; 40 male [63.5%]) participated in the survey. Interview participants perceived that PCPs function as gatekeepers in accessing PSA testing but may lack knowledge specific to Black men's risk for prostate cancer and hold attitudes about PSA testing that do not support its use. Interview participants also reported a lack of trusted relationships with PCPs to support shared decision-making. While both urologists and PCPs were highly aware of US Preventive Services Task Force guidelines, PCPs were much less likely than urologists to believe in the value of PSA testing or the role of early detection to prevent prostate cancer-related mortality (2 [6.5%] vs 24 [75.0%], respectively).

Conclusions and relevance: In this qualitative study examining structural factors associated with access to prostate cancer screening among Black individuals, findings from the survey supported participants' perceptions that PCPs do not value PSA testing for prostate cancer early detection or appreciate its role in reducing the risk of prostate cancer-related mortality. Primary care practitioner reliance on USPSTF guidelines, which currently do not provide guideline recommendations for screening high-risk groups, including Black individuals, suggests that incorporating evidence-driven guidance for PSA screening among Black individuals into these guidelines may substantially improve prostate cancer early detection among this high-risk population.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Pelman reported receiving grants from the Washington State Urology Society during the conduct of the study. Dr Nyame reported receiving personal fees from Ortho-Clinical Diagnostics outside the submitted work. No other disclosures were reported.

Figures

Figure.
Figure.. Prostate Cancer Disparities Theoretical Framework and Conceptual Model
See this image and copyright information in PMC

References

    1. Taksler GB, Keating NL, Cutler DM. Explaining racial differences in prostate cancer mortality. Cancer. 2012;118(17):4280-4289. doi: 10.1002/cncr.27379 - DOI - PubMed
    1. Frimpong NA, Holt SK, Carson D, et al. MP68-05: excess death and potential life years lost among Black prostate cancer patients (1970-2020). J Urol. 2024;211(suppl 5):e1109. doi: 10.1097/01.JU.0001008744.60568.e8.05 - DOI
    1. SEER*Stat Database: incidence - SEER research data, 9 registries, Nov 2019 sub (1975-2017) - linked to county attributes - time dependent (1990-2017) income/rurality, 1969-2018 counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2020, based on the November 2019 submission. Surveillance, Epidemiology, and End Results Program. Accessed March 19, 2023. https://www.seer.cancer.gov
    1. SEER*Stat Database: incidence - SEER 9 regs research data, Nov 2006 sub (1973-2004) - linked to county attributes - total U.S., 1969-2004 counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2007, based on the November 2006 submission. Surveillance, Epidemiology, and End Results Program. Accessed March 19, 2023. https://www.seer.cancer.gov
    1. Gulati R, Nyame YA, Lange JM, Shoag JE, Tsodikov A, Etzioni R. Racial disparities in prostate cancer mortality: a model-based decomposition of contributing factors. J Natl Cancer Inst Monogr. 2023;2023(62):212-218. doi: 10.1093/jncimonographs/lgad018 - DOI - PMC - PubMed

Substances